血管能抑素,Canstatin
1)Canstatin血管能抑素
1.Effects of Canstatin gene Transfected by Electroporation on Growth and Metastasis of Lewis Lung Carcinoma in C57 Mice;电转染血管能抑素基因对C_(57)小鼠Lewis肺癌生长和转移的影响
2.Cloning and Expression of Human Canstatin and its Purification and Bioactivity;人血管能抑素基因的克隆、表达及其表达产物的纯化和生物活性测定
3.Inhibitory effect of canstatin on neovascularization血管能抑素抑制新生血管生成的研究进展
英文短句/例句

1.Inhibitory effect of canstatin on neovascularization血管能抑素抑制新生血管生成的研究进展
2.A Study on the Expression of Canstatin in the Eukaryotic Cell and Its Biological Effects on Lung Cancer;血管能抑素基因在真核细胞中的表达及其抗肺癌作用的研究
3.Inhibitory effect of angiostatin on rat corneal neovascularization血管抑素抑制大鼠角膜新生血管的研究
4.Outlook of endostatin inhibit ocular neovascularization血管内皮抑素对眼内新生血管抑制的展望
5.Capsaicin Inhibits Angiotensin Ⅱ Induced Vasoconstriction in Mice辣椒素抑制血管紧张素Ⅱ介导的血管收缩
6.The Effects and the Possible Mechanism Involved in Vivo and Vitro of Ghrelin on Rat Vascular Calcification;生长素抑制大鼠血管钙化作用及其可能机制研究
7.Inhibition of restenosis by smearing estrogen on adventitia in the rat鼠血管外膜涂抹雌激素抑制血管再狭窄
8.Study on the Mechanism of Angiostatin in Antiangiogenesis of Tumor;血管抑素抗肿瘤血管生成机制的实验研究
9.Studies on Experimental Choroidal Neovascularization Inhibited by Endostatin Genetherapy;内皮抑素抑制脉络膜新生血管的实验研究
10.Experimental Study on the Inhibition of Corneal Neovascularization with Recombinant Human Endostatin;重组人内皮抑素抑制角膜新生血管的实验研究
11.NUMERICAL SIMULATION OF INHIBITORY EFFECTS OF ENDOSTATIN ON TUMOR ANGIOGENESIS内皮抑素抑制肿瘤血管生成的数值模拟
12.Effects of Angiotensin-converting Enzyme Inhibitors on Endothelial Function and the Number of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease;血管紧张素转换酶抑制剂对冠心病患者血管内皮功能及循环内皮祖细胞数量的影响
13.Kanamycin could inhibit the expression of NKCC1 in stria vascularis.卡那霉素可抑制血管纹NKCC1的表达;
14.② Purification of ACE inhibitory peptide;②血管紧张素转换酶抑制肽的纯化结果。
15.Studies on the Production of Angiostatin by Fermentation of Recombinant Escherichia Coli;重组大肠杆菌发酵产血管抑素的研究
16.The Study of the Biological Activity of the Recombinant Human Angiostatin K1-3;重组人血管抑素K1-3生物学活性研究
17.Study on Cloning Angiostatin Gene and Its Expressionin E.coli DH5α;血管抑素基因克隆及在E.coli DH5α的表达
18.Study on stability of angiotensin converting enzyme inhibitory peptides血管紧张素转化酶抑制肽稳定性研究
相关短句/例句

Canstatin人血管能抑素
1.Canstatin protein, a newly found angiogenesis inhibitor,has powerful anti-angiogenesis effect.人血管能抑素Canstatin是近年发现的血管生成抑制剂,具有强大的抑制血管生成作用。
3)canstatin人血管能抑制素
1.Construction of expression system of secretory canstatin vector and study of its biological effects;重组人血管能抑制素分泌型表达载体的构建及其生物学效应研究
4)Angiostatin[英][,?nd?i:??'st?tn][美][,?nd?io'st?tn]血管抑素
1.Optimization of Culture Medium for the Production of Recombinant Human Angiostatin;重组人血管抑素生产菌培养基优化的研究
2.Inhibition of Gliomas by Gene Transfer of Angiostatin in Nude Mice;血管抑素抑制胶质瘤的实验研究
3.Empirical study of angiostatin transfected gene therapy for gallbladder cancer;血管抑素基因转染抑制胆囊癌细胞的实验研究
5)human angiostatin人血管抑素
1.The fermentation conditions for production of recombinant human angiostatin (rhAGN) by E.对重组人血管抑素表达菌株pQE32 AGN的生长及产物表达规律进行了探索,确定了最佳发酵条件。
2.Human angiostatin, a 38 kD protein which is composed of 1-4 kringles of plasminogen, was separated and purified from serum and urine of lewis lung carcinoma by O Relly, et al.人血管抑素(angiostatin)是O Reilly等在Lewis肺癌小鼠的血清和尿液中分离纯化出的大小约为38 kD的蛋白质,它包含了血纤溶酶原(plasminogen)前4个环饼状结构域,即血管抑素(K1-4)。
6)Angiostatin[英][,?nd?i:??'st?tn][美][,?nd?io'st?tn]血管抑制素
1.Fusion Expression and Identification of Angiostatin and Endostatin in E.coli BL21(DE3);血管抑制素和内皮抑制素在大肠杆菌中的融合表达与鉴定
2.Construction of Eukaryotic Expressing Vector for Angiostatin Gene and Transfection into Pancreatic Cancer Cell;血管抑制素基因真核表达载体的构建及转染研究
3.Methods Angiostatin cDNA was amplified from normal human eukaryotic cells by using RT-PCR.目的构建受甲胎蛋白(AFP)增强子和白蛋白(Alb)启动子调控的含有血管抑制素(angiostatin)K5序列的真核表达载体,通过基因转染,将angiostatinK5基因导入肝癌细胞,观察angiostatinK5的表达。
延伸阅读

舒血管素 ,血管舒缓素药物名称:血管舒缓素英文名:Kallidinogenase别名: 保妥丁;激太积放酶;舒血管素 ,血管舒缓素外文名:Kallidinogenase适应症: 用于脑动脉硬化症、闭塞性动脉内膜炎、闭塞性血管炎、四肢慢性溃疡、肢端动脉痉挛症、手足发绀、老年性四肢冷感、中央视网膜炎、眼底出血等。也用于冠心病、心绞痛、视网膜血流障碍。 用量用法: 1.注射:临用时溶解(每1.5ml10单位)后进行肌注或皮注1次量10~20单位,每日1~2次。轻症每日10单位,以3周为1疗程。眼科亦可作眼结膜下注射,每次5单位。 2.口服:每次1片(含10单位),空腹时服。 注意事项: 1.凡肿瘤、颅内压增高、心力衰竭病人忌用。 2.有些病人应用后可出现疼痛反应。 3.本品对热、酸、碱、氧化剂均不稳定。 规格: 注射用血管舒缓素:每支10单位。片剂:每片10单位。 类别:周围血管扩张药